Quang T Luong

Summary

Publications

  1. ncbi request reprint Antitumor activity of suberoylanilide hydroxamic acid against thyroid cancer cell lines in vitro and in vivo
    Quang T Luong
    Department of Medicine and the Samuel Oschin Comprehensive Cancer Center, Cedars Sinai Medical Center, University of California at Los Angeles School of Medicine, Los Angeles, California 90048, USA
    Clin Cancer Res 12:5570-7. 2006
  2. ncbi request reprint Vitamin D compounds: activity against microbes and cancer
    Adrian F Gombart
    Division of Hematology Oncology, Cedars Sinai Medical Center, Burns and Allen Research Institute, David Geffen School of Medicine at UCLA, 8700 Beverly Blvd, Los Angeles, CA 90048, USA
    Anticancer Res 26:2531-42. 2006
  3. ncbi request reprint The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs
    Julian C Desmond
    Division of Medical Sciences, University of Birmingham, Birmingham, B15 2TH United Kingdom
    Cancer Res 63:505-12. 2003

Collaborators

  • Adrian F Gombart
  • James O'Kelly
  • Julian C Desmond
  • Martin Hewison
  • Jonathan P Ride
  • Mark T Drayson
  • Christopher M Bunce
  • Elio F Vanin
  • Elizabeth A Walker
  • Rachel E Hayden
  • Joanne C Mountford

Detail Information

Publications3

  1. ncbi request reprint Antitumor activity of suberoylanilide hydroxamic acid against thyroid cancer cell lines in vitro and in vivo
    Quang T Luong
    Department of Medicine and the Samuel Oschin Comprehensive Cancer Center, Cedars Sinai Medical Center, University of California at Los Angeles School of Medicine, Los Angeles, California 90048, USA
    Clin Cancer Res 12:5570-7. 2006
    ..The histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), has multiple antitumor effects against a variety of human cancers...
  2. ncbi request reprint Vitamin D compounds: activity against microbes and cancer
    Adrian F Gombart
    Division of Hematology Oncology, Cedars Sinai Medical Center, Burns and Allen Research Institute, David Geffen School of Medicine at UCLA, 8700 Beverly Blvd, Los Angeles, CA 90048, USA
    Anticancer Res 26:2531-42. 2006
    ..In this report, the anticancer and newly discovered antimicrobial actions of 1,25(OH)2D3 and deltanoids are reviewed...
  3. ncbi request reprint The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs
    Julian C Desmond
    Division of Medical Sciences, University of Birmingham, Birmingham, B15 2TH United Kingdom
    Cancer Res 63:505-12. 2003
    ..In addition, these observations identify AKR1C3 as plausible target for the non-cyclooxygenase-dependent antineoplastic actions of NSAIDs...